Instructions for Authors

Abstract

Get full access to this article

View all access options for this article.

References

Flegal, KM , Carroll, MD , Kuczmarski, RJ , et al: Overweight and obesity in the United States: Prevalence and trends 1960–1994. Int J Obes 22:39–47, 1998

NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health, June 1998

Lew EA , Garfinkel L : Variations in mortality by weight among 750,000 men and women. J Chron Dis 32:563–576, 1979.

Kremen AJ , Linner JH , Nelson CH : An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 140:439–448, 1954

Halverson JD , Scheff RJ , Gentry K , et al: Jejunoileal bypass. Late metabolic sequelae and weight gain. Am J Surg 140:347–350, 1980

Lowell JA , Shenoy S , Ghalib R , et al: Liver transplantation after jejunoileal bypass for morbid obesity. J Am Coll Surg 185:123–127, 1997

Mason EE , Ito C : Gastric bypass in obesity. Surg Clin North Am 47:1345–1352, 1967

Bothe A , Bistrian BR , Greenberg I : Energy regulation in morbid obesity by multidisciplinary therapy. Surg Clin North Am 59:1017–1031, 1979 xix

Halverson JD : Metabolic risk of obesity surgery and long-term follow-up. Am J Clin Nutr 55:602s–605s, 1992

10.

Mason EE : Vertical banded gastroplasty for obesity. Arch Surg 117:701–706, 1982

11.

Capella, JF , Capella RF : The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg 171: 74–74, 1996

12.

Brolin RE , Robertson LB , Kenler HA , et al: Weight loss and dietary intake after vertical banded gastroplasty and roux-en-bypass. Ann Surg 220:782–790, 1994

13.

Sugarman HJ , Londrey GL , Kellum JM , et al: Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 157:93–102, 1989

14.

Morino M , Toppino M , Garrone C , et al: Laparoscopic adjustable silicone gastric banding for the treatment of morbid obesity. Br J Surg 81: 1169, 1994

15.

Scopinaro N , Gianetta E , Civalleri D , et al: Bilio-pancreatic bypass for obesity. II. Initial experience in man. Br J Surg 66:618–620, 1979

16.

Cadiere GB , Bruyns J , Himpens J , et al: Laparoscopic gastroplasty for morbid obesity. Br J Surg 81:1524, 1994

17.

Lonroth H , Dalenback J : Other laparoscopic bariatric procedures. World J Surg 22:964–968, 1998

18.

Pories WJ , Swanson MS , MacDonald KG , et al: Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339–352, 1995

19.

Benotti, PN , Forse, RA : The role of gastric surgery in the multi-disciplinary management of severe obesity. Am J Surg 169:361–367, 1995

20.

MacLean LD , Rhode BM , Sampalis J , et al: Results of the surgical treatment of obesity. Am J Surg 165:155–159, 1993

21.

Martin LF , Tan T-L , Horn JR , et al: Comparison of the costs associated with medical and surgical treatment of obesity. Surgery 118:599–607, 1995

22.

Printen KJ , Mason EE : Gastric bypass for morbid obesity for patients >50 years of age. Surg Gynecol Obstet 144:192–194, 1977

23.

MacGregor AMC , Rand CS : Gastric surgery in morbid obesity. Outcome in patients aged 55 and older. Arch Surg 128:1153–1157, 1993

24.

Avinoah E , Ovnat A , Charuzi I : Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery 111:137–142, 1992

25.

Halverson JD : Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg 52:594–598, 1986

26.

Amaral JF , Thompson WR , Caldwell MD , et al: Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity. Ann Surg 201:186–192, 1985

27.

Rhode BM , Arseneau P , Cooper BA , et al: Vitamin B-12 deficiency after gastric bypass surgery for obesity. Am J Clin Nutr 63:103–109, 1996

28.

Printen KJ , Halverson JD : Hemic micronutrients following vertical banded gastroplasty. Am Surg 54:267–268, 1988

29.

Smith CD , Herkes SB , Behrns KE , et al: Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg 218:91–96, 1993

30.

Mahmud K , Ripley D , Dolscherholmen A : Vitamin B12 absorption tests: Their unreliability in postgastrectomy states. JAMA 216:1167–1171, 1971

31.

Crowley LV , Olson RW : Megaloblastic anemia after gastric bypass for obesity. Am J Gastroenterol 79:850–860, 1984

32.

Marcuard SP , Sinar DR , Swanson MS , et al: Absence of luminal intrinsic factor after gastric bypass surgery for morbid obesity. Dig Dis Sci 34:1238–1242, 1989

33.

Fobi RIA,L , Lee H , Holness R , et al: Gastric bypass operation for obesity. World J Surg 22:925–935, 1998

34.

Sugarman HJ , Brewer WH , Shiffman ML , et al: A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 169:91–97, 1995

35.

Scopinaro N , Adami GF , Marinari GM , et al: Biliopancreatic diversion. World J Surg 22:936–946, 1998

36.

Herbst CA , Hughes TA , Gwynne JT , et al: Gastric bariatric operation in insulin-treated adults. Surgery 95:209–214, 1984.

37.

Gleysteen JJ , Barboriak JJ , Sasse EA : Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr 51:774–778, 1990

38.

Alport MA , Singh A , Terry BE , et al: Effect of exercise on left ventricular systolic function and reserve in morbid obesity. Am J Card 63:1478–1482, 1989

39.

Foley EF , Benotti PN , Borlase BC , et al: Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg 186:294–297, 1992

40.

Sugarman HJ , Fairman RP , Baron PL , et al: Gastric surgery for respiratory insufficiency of obesity. Chest 90:81–86, 1986

41.

Kuczmarski RJ , Flcgal KM , Campbell SM , et al: Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination surveys, 1960-1991. JAMA 272:205–211, 1994

42.

Hill JO , Wyatt HR : Relapse in obesity treatment: Biology or behavior? Am J Clin Nutr 69:1064–1065, 1999

43.

Wolf AM : What is the economic case for treating obesity? Obes Res 6:2S–7S, 1998

44.

Kuczmarski RJ , Carrol MD , Flegal KM , et al: Varying body mass index cutoff points to describe overweight prevalence among US adults: NHANES III (1988–1994). Obes Res 5:542–548, 1997

45.

Wadden TA : Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials. Ann Intern Med 119:688–693, 1993

46.

Aronne, LJ : Modern medical management of obesity: The role of pharmaceutical intervention J Am Diet Assoc 98(Suppl 2):S23–S26, 1998

47.

Leibel RL , Rosenbaum M , Hirsch J : Changes in energy expenditure resulting from altered body weight. N Engl J Med 332:621–628, 1995

48.

Campfield AL , Smith FJ , Burn P : Strategies and potential molecular targets for obesity treatment. Science 280:1383–1387, 1998

49.

Mantzoros CS : The role of leptin in human obesity and disease: A review of current evidence. Ann Intern Med 130:671–680, 1999

50.

Hill JO , Peters JC : Environmental contributions to the obesity epidemic. Science 280:1371–1374, 1998

51.

Colditz GA , Willett WC , Rotnitzky A , et al: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481–486, 1995

52.

Blackburn G : Effect of degree of weight loss on health benefits. Obes Res 3(Suppl):211s–216s, 1995

53.

Huang Z , Willett WC , Manson JE , et al: Body weight, weight change, and risk for hypertension in women. Ann Intern Med 128:81–88, 1998

54.

Van Itallie TB : Health Implications of overweight and obesity in the United States. Ann Intern Med 103:983–988, 1985

55.

Pi-Sunyer FX : Medical hazards of obesity. Ann Intern Med 119(pt 2):655–660, 1993

56.

Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413–2446, 1997

57.

Hsueh WA , Buchanan TA : Obesity and hypertension. Endocrinol Metab Clin North Am 23:405–427, 1994

58.

Eckel RH : Obesity and heart disease: A statement for health care professionals from the nutrition committee, American Heart Association. Circulation 96:3248–3250, 1997

59.

Rimm EB , Stampfer MJ , Giovannucci E , et al: Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol 141:1117–1127, 1995

60.

Manson JE , Willett WC , Stampfer MJ , et al: Body weight and mortality among women. N Engl J Med 333:677–685, 1995

61.

Alexander JK : The cardiomyopathy of obesity. Prog Cardiovasc Dis 27:325–333, 1985

62.

Matts JP , Buchwald H , Fitch LL , et al: Subgroup analyses of the major clinical endpoints in the program on the surgical control of the hyperlipidemias (Posch): Overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and AC HD mortality or myocardial infarction. J Clin Epidemiol 48:389–405, 1995

63.

Guilleminault C : Clinical features and evaluation of obstructive sleep apnea. IN Principles and Practice of Sleep Medicine, Kryger MH , Roth T , Dement WC (Eds), WB Saunders, Philadelphia, PA, 552–558, 1989

64.

Vgontzas AN , Tan TL , Bixler EO , et al: Sleep apnea and sleep disruption in obese patients. Arch Int Med 154:1705–1711, 1994

65.

Strollo PJ , Rogers RM : Current concepts: Obstructive sleep apnea. N Engl J Med 34:99–104, 1996

66.

Kansnen M , Vanninen E , Tuunainen A , et al: The effect of a very low-calorie diet-induced weight loss on the severity of obstructive sleep apnea and autonomic nervous function in obese patients with obstructive sleep apnea syndrome. Clin Physiol 18:377–385, 1998

67.

Stampfer MJ , Maclure KM , Colditz GA , et al: Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr 55:652–658, 1992

68.

Everhart, JE : Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 119:1029–1035, 1993

69.

Syngal S , Coakley EH , Willett WC , et al: Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med 130:471–477, 1999

70.

Shiffman ML , Kaplan GD , Brinkman-Kaplan V , et al: Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med 122:899–905, 1995

71.

National Institutes of Health/National Heart, Lung, and Blood Institute/Obesity Education Initiative Expert Panel: The Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res 6(Suppl 2):51S–209S, 1998

72.

Weintraub M , Sundaresan PR , Madan M , et al: Long-term weight control study I (weeks 0 to 34): the enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo. Clin Pharmacol Ther 51:586, 1992

73.

US Dept of Health and Human Services: Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine. US Dept of Health and Human Services interim public health recommendations. Morb Mortal Wkly Rep 46:1, 1997

74.

Langlois KJ , Forbes JA , Bell GW , et al: A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity. Curr Therapeutic Res, Clin Experimental 16:289–296, 1974

75.

Bray GA , Ryan DH : Drugs used in the treatment of obesity. Diab Rev 5:83–103, 1997

76.

Klein S : The war against obesity: Attacking a new front. Am J Clin Nutr 69:1061–1063, 1999

77.

Astrup A , Buemann B , Cristensen NJ , et al: Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women. Am J Physiol 266:E592–E599, 1994

78.

Hill JO , Hauptman J , Anderson JW , et al: Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: A 1-year study. Am J Clin Nutr 69:1108–1116, 1999

79.

Langford HG , Davis BR , Blaufox D , et al: Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group. Hypertension 17:210–217, 1991

80.

Wood PD , Stefanick ML , Williams PT , et al: The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 325:461–466, 1991

81.

Simkin-Silverman L , Wing RR , Hansen DH , et al: Prevention of cardiovascular risk factor elevations in healthy premenopausal women. Prev Med 24:509–517, 1995

82.

National Institutes of Health, National Task Force on the Prevention and Treatment of Obesity: Very low-calorie diets. JAMA 270:967–974, 1993

83.

Wadden TA , Foster GD , Letizia KA : One-year behavioral treatment of obesity: Comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J Consult Clin Psychol 62:165–171, 1994

84.

Vanltallie TB , Yang M-U : Current concepts in nutrition: Diets and weight loss. N Engl J Med 297:1158–1161, 1977

85.

Prentice AM , Jebb SA : Obesity in Britain. Gluttony or sloth? Br Med J 311:437–439, 1995

86.

American Heart Association: Scientific statement on guidelines for weight management programs in healthy adults. Heart Dis Stroke 3:221–228, 1994

87.

US Department of Health and Human Services: Physical activity and health: A report of the Surgeon General. US Dept of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA.1996

88.

Kayman S , Bruvold W , Stern JS : Maintenance and relapse after weight loss in women: behavioral aspects. Am J Clin Nutr 52:800–807, 1990

89.

Pate RR , Pratt M , Blair SN , et al: Physical activity and public health: A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273:402–407, 1995

90.

Andersen RE , Wadden TA , Bartlett SJ , et al: Effects of lifestyle activity vs structured aerobic exercise in obese women: A randomized trial. JAMA 281:335–340, 1999

91.

Wadden TA : The treatment of obesity. IN Obesity: Theory and Therapy, Stunkard AJ , Wadden TA (Eds). Raven Press, New York, 1993, pp 197–217